NEW YORK (GenomeWeb) — Prescient Medicine — a provider of toxicology, pharmacogenomic, and other testing services — has partnered with Metabiomics to develop microbiome diagnostic assays for colon cancer and other gastrointestinal diseases, the companies said today.